FDA & Government News

May 27, 2026

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

Conexiant

May 21, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Conexiant

April 23, 2026

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

Conexiant

April 16, 2026

When ‘Family Planning’ Shifts Meaning

A program built on prevention now tilts toward population goals, testing the balance between public health and personal choice.

Kff Health News

April 16, 2026

When ‘Family Planning’ Shifts Meaning

A program built on prevention now tilts toward population goals, testing the balance between public health and personal choice.

Kff Health News

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

April 10, 2026

Injectable Targets Décolleté Wrinkles

New indication expands use of injectable biostimulator beyond the face.

Conexiant

March 26, 2026

FDA Clears AI Guidance Tool for Mitral Repair

AI enhances real-time intraprocedural visualization and navigation.

Conexiant

March 26, 2026

St. Louis Pediatrician Gets 20-Year Sentence

A physician exploited patients with addiction for nearly a decade, trading prescriptions for sex acts, photos, and cash

Conexiant

March 17, 2026

Consent Conflicts in Organ Donation

Variability in registry rules raises questions about autonomy and oversight.

Kff Health News

March 12, 2026

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Conexiant

Postop Pain Differs by Vitamin D Status

FDA & Government News

FDA OKs Linaclotide in Young Children

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

FDA Grants Accelerated Approval for OTOF Gene Therapy

When ‘Family Planning’ Shifts Meaning

When ‘Family Planning’ Shifts Meaning

Daily News

Injectable Targets Décolleté Wrinkles

FDA Clears AI Guidance Tool for Mitral Repair

St. Louis Pediatrician Gets 20-Year Sentence

Consent Conflicts in Organ Donation

Cataract Surgeons Gain a New Lens Tool

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Postop Pain Differs by Vitamin D Status

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The Pathologist

FDA & Government News

Daily News

Recommendations